BSAC Infection Learning Hub
Open access global learning
All courses accredited
4 January 2021
A novel virtual screening procedure identifies Pralatrexate as inhibitor of SARS-CoV-2 RdRp and it reduces viral replication in vitro
Navigation
Home
COVID-19 Resource Hub
Webinars
Work with us
Latest news
What they say about us
Top
